Skip to main content Help with accessibility Skip to main navigation

INFLIXIMAB infusion (including biosimilars) in rheumatological conditions

Last Updated: 11 April 2018

Body System: Musculoskeletal system


The Pan Mersey Area Prescribing Committee recommends the prescribing of infliximab infusion for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis and adult-onset Still’s disease, as well as in patients fitting other criteria commissioned by Pan Mersey CCGs, as listed.